Exact Sciences
EXAS
#1767
Rank
ยฃ7.37 B
Marketcap
ยฃ39.84
Share price
-3.29%
Change (1 day)
-18.51%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -ยฃ0.13 Billion

According to Exact Sciences's latest financial reports the company's current earnings are ยฃ2.61 Billion. In 2023 the company made an earning of -ยฃ0.15 Billion, an increase over its 2022 earnings that were of -ยฃ0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ0.13 Billion-14.93%
2023 -ยฃ0.15 Billion-69.98%
2022 -ยฃ0.48 Billion-25.55%
2021 -ยฃ0.65 Billion1.68%
2020 -ยฃ0.64 Billion271.17%
2019 -ยฃ0.18 Billion58.99%
2018 -ยฃ0.11 Billion20.89%
2017 -ยฃ88.53 Million-30.95%
2016 -ยฃ0.13 Billion5.09%
2015 -ยฃ0.13 Billion57.24%
2014 -ยฃ77.59 Million116.53%
2013 -ยฃ35.84 Million
2011 -ยฃ22.31 Million143.73%
2010 -ยฃ9.16 Million27.85%
2009 -ยฃ7.16 Million0.27%
2008 -ยฃ7.14 Million-20.95%
2007 -ยฃ9.04 Million-13.53%
2006 -ยฃ10.45 Million-10.07%
2005 -ยฃ11.62 Million-21.81%
2004 -ยฃ14.86 Million-33.44%
2003 -ยฃ22.32 Million-6.51%
2002 -ยฃ23.88 Million17.95%
2001 -ยฃ20.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.12 Billion-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ50.99 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ42.41 Million-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ27.07 Million-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.73 B-4,883.42%๐Ÿ‡ซ๐Ÿ‡ท France